ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO780

Colostomy in Children on Chronic Peritoneal Dialysis

Session Information

  • Pediatric CKD
    November 07, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1700 Pediatric Nephrology

Authors

  • Chan, Yu hin Eugene, Hong Kong Children's Hospital, Hong Kong, Hong Kong
  • Borzych-duzalka, Dagmara, Medical University of Gdansk, Gdansk, Poland
  • Schaefer, Franz S., University of Heidelberg, Heidelberg, BW, Germany
  • Warady, Bradley A., Children's Mercy Kansas City, Kansas City, Missouri, United States

Group or Team Name

  • International Pediatric Peritoneal Dialysis Network
Background

The aim of this study was to evaluate the outcome of children on chronic peritoneal dialysis (PD) with a concurrent colostomy.

Methods

Patients were identified through the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Age-matched controls were randomly selected from the registry. Data were collected through the IPPN database and a survey disseminated to all participating sites.

Results

15 centers reported 20 children who received chronic PD with a co-existing colostomy. The commonest cause of end-stage kidney disease was congenital anomalies of kidney and urinary tract (n=16, 80%). The main reason for placement of a colostomy was anorectal malformation (n=13, 65%). The median age at colostomy creation and PD catheter (PDC) insertion were 0.1 [IQR, 0-2.2] and 2.8 [IQR 0-2.2] months, respectively. The colostomies and PDCs were present together for a median 18 [IQR, 4.9-35.8] months. The median age at PDC placement in 46 controls was 4.2 [IQR, 3.6-10.8] months.

14 patients (70%) developed 39 episodes of peritonitis. The annualized peritonitis rate was significantly higher in the colostomy group (1.13 vs 0.70 episodes per patient year; p=0.02). Predominant causative microorganisms were staphylococcus aureus (15%) and pseudomonas aeruginosa (13%). There were 10 exit site infections (ESI) episodes reported exclusively in colostomy patients. Seven children (35%) died during their course of PD, in two cases due to peritonitis.

Conclusion

Although chronic PD is feasible in children with a colostomy, it is associated with an increased risk of peritonitis, ESI, and mortality. Continued efforts to reduce the infection risk for this complex patient population are essential.